From professional translators, enterprises, web pages and freely available translation repositories.
dokazano je zmanjšanje pojavnosti vretenčnih, ne pa tudi nevretenčnih zlomov.
a reduction in the incidence of vertebral, but not of non-vertebral fractures has been demonstrated.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
v incidenci novih nevretenčnih zlomov ni bilo razlik med zdravljenimi skupinami.
there was no difference between treatment groups in the incidence of new nonvertebral fractures.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
dokazano je bilo zmanjšanje pogostosti vretenčnih zlomov, ne pa tudi nevretenčnih zlomov “.
a reduction in the incidence of vertebral, but not of non-vertebral fractures has been demonstrated”.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
zdravljenje z 2,5 mg na dan je povzročilo progresivno zvečanje mkg vretenc in nevretenčnih delov skeleta.
daily treatment with 2.5 mg resulted in progressive increases in bmd at vertebral and nonvertebral sites of the skeleton.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
pri ženskah po menopavzi so dokazali pomembno znižanje pojavnosti vretenčnih in nevretenčnih zlomov, ne pa tudi zlomov kolka.
in postmenopausal women, a significant reduction in the incidence of vertebral and non- vertebral fractures but not hip fractures has been demonstrated.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
peroralno zdravljenje z 2,5-mg tabletami ibandronske kisline enkrat na dan je povzročilo progresivno povišanje mkg vretenc in nevretenčnih delov skeleta.
daily oral treatment with ibandronic acid 2.5 mg tablets resulted in progressive increases in bmd at vertebral and nonvertebral sites of the skeleton.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
pri teh bolnicah je bilo dokazano, da zdravilo forsteo znatno zmanjšuje pojavnost zlomov vretenc (hrbtenice) in nevretenčnih zlomov, ne pa tudi zlomov kolka;
in these patients, forsteo has been shown to significantly reduce vertebral (spine) and non-vertebral fractures (broken bones), but not those of the hip;
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
zdravilo fablyn je signifikantno zmanjšalo pogostnost nevretenčnih zlomov z 10,4 % pri placebu na 8,1 % pri zdravilu fablyn (relativno zmanjšanje tveganja = 24 %, p = 0,0020).
fablyn significantly decreased the incidence of non-vertebral fractures from 10.4% for placebo to 8.1% for fablyn (relative risk reduction = 24%, p = 0.0020).
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
